100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human BLyS/TNFSF13B/BAFF Recombinant Protein (RPES2575)

SKU RPES2575
Product Type Recombinant Protein
Species Human
Application Area Cytokines & Chemokines
$1,806 - $10,217

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human BLyS/TNFSF13B/BAFF Recombinant Protein

B lymphocyte stimulator (BLyS); also known as TNFSF13B; CD257 and BAFF; is a single-pass type II membrane protein; which belongs to the tumour necrosis factor family. BAFF is highly expressed in peripheral blood Leukocytes and is only present in monocytes and macrophages. BAFF is a cytokine and serves as a ligand for receptors TNFRSF13B (TACI); TNFRSF17 (BCMA); and TNFRSF13C (BAFFR). The activation of these receptors is important for B cell development, homeostasis, and antigen selection. BLyS levels affect survival signals and selective apoptosis of autoantibody-producing B cells. BAFF acts as a powerful B-cell activator, and it has been found to be essential in the proliferation and differentiation of B cells. When BlyS is overexpressed in mice, both clinical and serological symptoms of systemic lupus erythematosus (SLE) and Sjogren's syndrome can be observed (SS). BLyS is an attractive therapeutic target in human rheumatic diseases. The potential of BLyS to control both the size and variety of the peripheral B cell compartment opens the possibility that BLyS and antagonists thereof may serve as the foundation for a three-pronged therapy. As an agonist, BLyS protein may improve humoral immunity in individuals with congenital or acquired immunodeficiencies caused by a viral infection or cancer therapy. Human BLyS/TNFSF13B/BAFF Recombinant Protein is a highly pure recombinant protein developed by Assay Genie for use in a range of applications.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose